1 Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. Why investors ...

Current price $159.27 52-week high $171.37 ...

Barclays analyst Lauren Lieberman maintained a Sell rating on Clorox (CLX – Research Report) today and set a price target of $130.00. The company’s shares closed yesterday at $160.47.

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

**NM signifies a non meaningful value. A dash signifies the data is not available.

In a report released on January 15, Nik Modi from RBC Capital maintained a Hold rating on Clorox (CLX – Research Report), with a price target of $150.00. The company’s shares closed yesterday ...

The Clorox Company (CLX), headquartered in Oakland, California, manufactures and sells consumer and professional products.

Jan. 8, 2025 — A research team has achieved a groundbreaking quantum simulation of the non-Hermitian skin effect in two dimensions using ultracold fermions, marking a significant advance in ...